Balance Wealth’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$377K Sell
8,708
-638
-7% -$27K 0.1% 111
2026
Q1
$364K Sell
9,346
-28,370
-75% -$1.15M 0.11% 110
2025
Q4
$1.54M Sell
37,716
-1,115
-3% -$45.4K 0.49% 50
2025
Q3
$1.57M Sell
38,831
-15,894
-29% -$613K 0.39% 44
2025
Q2
$2.01M Sell
54,725
-247,294
-82% -$8.37M 1.18% 23
2025
Q1
$10M Buy
+302,019
New +$10.5M 6.52% 3

Other funds holding RECS

Balance Wealth's RECS Position: Q2 2026 in Review

Balance Wealth reduced its Columbia Research Enhanced Core ETF (RECS) stake by 6.8% in Q2 2026, selling an estimated $27K and leaving 8,708 shares worth $377K. The position accounts for 0.1% of the portfolio, ranked #111.

Balance Wealth first reported a position in RECS in Q1 2025 and has held it in 6 quarters since. The position peaked at $10M in Q1 2025. 186 funds tracked by Wall St. Rank hold RECS as of Q2 2026.

  • Balance Wealth held 8,708 shares of Columbia Research Enhanced Core ETF worth $377K as of Q2 2026.
  • Balance Wealth sold 638 Columbia Research Enhanced Core ETF shares in Q2 2026, an estimated $27K.
  • Columbia Research Enhanced Core ETF made up 0.1% of Balance Wealth's portfolio in Q2 2026, its #111 holding.
  • Balance Wealth first reported a position in Columbia Research Enhanced Core ETF in Q1 2025 and has held it in 6 quarters since.
  • Balance Wealth's Columbia Research Enhanced Core ETF position peaked at $10M in Q1 2025.
  • 186 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q2 2026.

Based on Balance Wealth's 13F filing for Q2 2026, filed 22 Jul 2026.